ユーザーIDをお忘れですか? or パスワードをお忘れですか?

東京ビッグサイト | 有明

2018年11月11日 (日) 午前 9:30 - 2018年11月13日 (火) 午後 5:40

〒135-0063, 東京都江東区有明3-11-1



[V4-S1] Overview of Cancer Genome Precision Medicine in Medical Practice - Oncology Panels and CDxs -

Session Chair(s)

Yasuhiro  Fujiwara, MD, PhD

Yasuhiro Fujiwara, MD, PhD

Chief Executive

Pharmaceuticals and Medical Devices Agency (PMDA), Japan

To promote precision medicine in cancer treatment, related issues are discussed and possible approaches were proposed in the report of “Consortium on Promotion for Cancer Genome Medicine” held in 2017. In this session, current status of oncology panel and CDx in Japan as well as cases in Senshin Iryo-B will be overviewed and the remaining issues for the implementation of cancer precision medicine in Japan will be discussed from industry, academia and government point of view.


Katsutoshi  Oda, MD, PhD

Clinical Sequencing by Todai OncoPanel, a Multiplex Cancerrelated Gene Panel Testing

Katsutoshi Oda, MD, PhD

The University of Tokyo, Japan

Graduate School of Medicine

Kuniko  Sunami, MD, PhD

Implementation of the NGS-based test “NCC-Oncopanel” for Precision Cancer Medicine

Kuniko Sunami, MD, PhD

National Cancer Center, Japan

Department of Pathology and Clinical Laboratories

Reiko  Yanagihara, PhD

PMDA Perspectives on Oncology Panel

Reiko Yanagihara, PhD

Pharmaceuticals and Medical Devices Agency (PMDA), Japan

Deputy Review Director, Office of In Vitro Diagnostics

Kosuke  Iijima

Kosuke Iijima

Chugai Pharmaceutical Co., Ltd., Japan

Department Manager, PHC Strategy Dept. Project & Lifecycle Management Unit

Kiyo  Ishikura, PhD

Kiyo Ishikura, PhD

PFDeNA Inc., Japan